Global Biosimilar Sales Market Report 2018

June 2018 | 108 pages | ID: G7E98ECA7ACEN
QYResearch

Abstracts

This report studies the global Biosimilar market status and forecast, categorizes the global Biosimilar market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Biosimilar market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibody
• Hormone
• Growth Factors
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

The study objectives of this report are:

• To analyze and study the global Biosimilar sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Biosimilar players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Biosimilar Manufacturers
Biosimilar Distributors/Traders/Wholesalers
Biosimilar Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biosimilar market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Biosimilar Sales Market Report 2018

1 BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar
1.2 Classification of Biosimilar by Product Category
  1.2.1 Global Biosimilar Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Antibody
  1.2.4 Hormone
  1.2.5 Growth Factors
  1.2.6 Other
1.3 Global Biosimilar Market by Application/End Users
  1.3.1 Global Biosimilar Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Hemophilia
  1.3.5 Other
1.4 Global Biosimilar Market by Region
  1.4.1 Global Biosimilar Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Biosimilar Status and Prospect (2013-2025)
  1.4.3 Europe Biosimilar Status and Prospect (2013-2025)
  1.4.4 China Biosimilar Status and Prospect (2013-2025)
  1.4.5 Japan Biosimilar Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Biosimilar Status and Prospect (2013-2025)
  1.4.7 India Biosimilar Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Biosimilar (2013-2025)
  1.5.1 Global Biosimilar Sales and Growth Rate (2013-2025)
  1.5.2 Global Biosimilar Revenue and Growth Rate (2013-2025)

2 GLOBAL BIOSIMILAR COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biosimilar Market Competition by Players/Suppliers
  2.1.1 Global Biosimilar Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Biosimilar Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Biosimilar (Volume and Value) by Type
  2.2.1 Global Biosimilar Sales and Market Share by Type (2013-2018)
  2.2.2 Global Biosimilar Revenue and Market Share by Type (2013-2018)
2.3 Global Biosimilar (Volume and Value) by Region
  2.3.1 Global Biosimilar Sales and Market Share by Region (2013-2018)
  2.3.2 Global Biosimilar Revenue and Market Share by Region (2013-2018)
2.4 Global Biosimilar (Volume) by Application

3 UNITED STATES BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biosimilar Sales and Value (2013-2018)
  3.1.1 United States Biosimilar Sales and Growth Rate (2013-2018)
  3.1.2 United States Biosimilar Revenue and Growth Rate (2013-2018)
  3.1.3 United States Biosimilar Sales Price Trend (2013-2018)
3.2 United States Biosimilar Sales Volume and Market Share by Players (2013-2018)
3.3 United States Biosimilar Sales Volume and Market Share by Type (2013-2018)
3.4 United States Biosimilar Sales Volume and Market Share by Application (2013-2018)

4 EUROPE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Biosimilar Sales and Value (2013-2018)
  4.1.1 Europe Biosimilar Sales and Growth Rate (2013-2018)
  4.1.2 Europe Biosimilar Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Biosimilar Sales Price Trend (2013-2018)
4.2 Europe Biosimilar Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Biosimilar Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Biosimilar Sales Volume and Market Share by Application (2013-2018)

5 CHINA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 China Biosimilar Sales and Value (2013-2018)
  5.1.1 China Biosimilar Sales and Growth Rate (2013-2018)
  5.1.2 China Biosimilar Revenue and Growth Rate (2013-2018)
  5.1.3 China Biosimilar Sales Price Trend (2013-2018)
5.2 China Biosimilar Sales Volume and Market Share by Players (2013-2018)
5.3 China Biosimilar Sales Volume and Market Share by Type (2013-2018)
5.4 China Biosimilar Sales Volume and Market Share by Application (2013-2018)

6 JAPAN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biosimilar Sales and Value (2013-2018)
  6.1.1 Japan Biosimilar Sales and Growth Rate (2013-2018)
  6.1.2 Japan Biosimilar Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Biosimilar Sales Price Trend (2013-2018)
6.2 Japan Biosimilar Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Biosimilar Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Biosimilar Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biosimilar Sales and Value (2013-2018)
  7.1.1 Southeast Asia Biosimilar Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Biosimilar Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Biosimilar Sales Price Trend (2013-2018)
7.2 Southeast Asia Biosimilar Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Biosimilar Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Biosimilar Sales Volume and Market Share by Application (2013-2018)

8 INDIA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 India Biosimilar Sales and Value (2013-2018)
  8.1.1 India Biosimilar Sales and Growth Rate (2013-2018)
  8.1.2 India Biosimilar Revenue and Growth Rate (2013-2018)
  8.1.3 India Biosimilar Sales Price Trend (2013-2018)
8.2 India Biosimilar Sales Volume and Market Share by Players (2013-2018)
8.3 India Biosimilar Sales Volume and Market Share by Type (2013-2018)
8.4 India Biosimilar Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biosimilar Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biosimilar Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Roche Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Eli Lilly
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biosimilar Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Eli Lilly Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Bayer
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biosimilar Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Bayer Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Amgen
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biosimilar Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Amgen Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Sanofi-Aventis
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biosimilar Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Sanofi-Aventis Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biosimilar Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Johnson & Johnson Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Novo Nordisk
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biosimilar Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novo Nordisk Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Merck
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biosimilar Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Merck Biosimilar Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview

10 BIOSIMILAR MAUFACTURING COST ANALYSIS

10.1 Biosimilar Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biosimilar
10.3 Manufacturing Process Analysis of Biosimilar

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biosimilar Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOSIMILAR MARKET FORECAST (2018-2025)

14.1 Global Biosimilar Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Biosimilar Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Biosimilar Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Biosimilar Price and Trend Forecast (2018-2025)
14.2 Global Biosimilar Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Biosimilar Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Biosimilar Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Biosimilar Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Biosimilar Sales Forecast by Type (2018-2025)
  14.3.2 Global Biosimilar Revenue Forecast by Type (2018-2025)
  14.3.3 Global Biosimilar Price Forecast by Type (2018-2025)
14.4 Global Biosimilar Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar
Figure Global Biosimilar Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Biosimilar Sales Volume Market Share by Type (Product Category) in 2017
Figure Antibody Product Picture
Figure Hormone Product Picture
Figure Growth Factors Product Picture
Figure Other Product Picture
Figure Global Biosimilar Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Biosimilar by Application in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Biosimilar Market Size (Million USD) by Regions (2013-2025)
Figure United States Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biosimilar Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Biosimilar Sales Volume (K Units) (2013-2018)
Table Global Biosimilar Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Biosimilar Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Biosimilar Sales Share by Players/Suppliers
Figure 2017 Biosimilar Sales Share by Players/Suppliers
Figure Global Biosimilar Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biosimilar Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biosimilar Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Biosimilar Revenue Share by Players
Table 2017 Global Biosimilar Revenue Share by Players
Table Global Biosimilar Sales (K Units) and Market Share by Type (2013-2018)
Table Global Biosimilar Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Biosimilar by Type (2013-2018)
Figure Global Biosimilar Sales Growth Rate by Type (2013-2018)
Table Global Biosimilar Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Biosimilar Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar by Type (2013-2018)
Figure Global Biosimilar Revenue Growth Rate by Type (2013-2018)
Table Global Biosimilar Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Biosimilar Sales Share by Region (2013-2018)
Figure Sales Market Share of Biosimilar by Region (2013-2018)
Figure Global Biosimilar Sales Growth Rate by Region in 2017
Table Global Biosimilar Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biosimilar Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biosimilar by Region (2013-2018)
Figure Global Biosimilar Revenue Growth Rate by Region in 2017
Table Global Biosimilar Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biosimilar Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biosimilar by Region (2013-2018)
Figure Global Biosimilar Revenue Market Share by Region in 2017
Table Global Biosimilar Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Biosimilar Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Biosimilar by Application (2013-2018)
Figure Global Biosimilar Sales Market Share by Application (2013-2018)
Figure United States Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure United States Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table United States Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table United States Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure United States Biosimilar Sales Volume Market Share by Players in 2017
Table United States Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table United States Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure United States Biosimilar Sales Volume Market Share by Type in 2017
Table United States Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table United States Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure United States Biosimilar Sales Volume Market Share by Application in 2017
Figure Europe Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table Europe Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure Europe Biosimilar Sales Volume Market Share by Players in 2017
Table Europe Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table Europe Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure Europe Biosimilar Sales Volume Market Share by Type in 2017
Table Europe Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table Europe Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure Europe Biosimilar Sales Volume Market Share by Application in 2017
Figure China Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure China Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table China Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table China Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure China Biosimilar Sales Volume Market Share by Players in 2017
Table China Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table China Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure China Biosimilar Sales Volume Market Share by Type in 2017
Table China Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table China Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure China Biosimilar Sales Volume Market Share by Application in 2017
Figure Japan Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table Japan Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure Japan Biosimilar Sales Volume Market Share by Players in 2017
Table Japan Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table Japan Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure Japan Biosimilar Sales Volume Market Share by Type in 2017
Table Japan Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table Japan Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure Japan Biosimilar Sales Volume Market Share by Application in 2017
Figure Southeast Asia Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Biosimilar Sales Volume Market Share by Players in 2017
Table Southeast Asia Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Biosimilar Sales Volume Market Share by Type in 2017
Table Southeast Asia Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Biosimilar Sales Volume Market Share by Application in 2017
Figure India Biosimilar Sales (K Units) and Growth Rate (2013-2018)
Figure India Biosimilar Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Biosimilar Sales Price (USD/Unit) Trend (2013-2018)
Table India Biosimilar Sales Volume (K Units) by Players (2013-2018)
Table India Biosimilar Sales Volume Market Share by Players (2013-2018)
Figure India Biosimilar Sales Volume Market Share by Players in 2017
Table India Biosimilar Sales Volume (K Units) by Type (2013-2018)
Table India Biosimilar Sales Volume Market Share by Type (2013-2018)
Figure India Biosimilar Sales Volume Market Share by Type in 2017
Table India Biosimilar Sales Volume (K Units) by Application (2013-2018)
Table India Biosimilar Sales Volume Market Share by Application (2013-2018)
Figure India Biosimilar Sales Volume Market Share by Application in 2017
Table Pfizer Basic Information List
Table Pfizer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biosimilar Sales Growth Rate (2013-2018)
Figure Pfizer Biosimilar Sales Global Market Share (2013-2018)
Figure Pfizer Biosimilar Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biosimilar Sales Growth Rate (2013-2018)
Figure Roche Biosimilar Sales Global Market Share (2013-2018)
Figure Roche Biosimilar Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Biosimilar Sales Growth Rate (2013-2018)
Figure Eli Lilly Biosimilar Sales Global Market Share (2013-2018
Figure Eli Lilly Biosimilar Revenue Global Market Share (2013-2018)
Table Bayer Basic Information List
Table Bayer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Biosimilar Sales Growth Rate (2013-2018)
Figure Bayer Biosimilar Sales Global Market Share (2013-2018)
Figure Bayer Biosimilar Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biosimilar Sales Growth Rate (2013-2018)
Figure Amgen Biosimilar Sales Global Market Share (2013-2018)
Figure Amgen Biosimilar Revenue Global Market Share (2013-2018)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi-Aventis Biosimilar Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis Biosimilar Sales Global Market Share (2013-2018
Figure Sanofi-Aventis Biosimilar Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biosimilar Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Biosimilar Sales Global Market Share (2013-2018)
Figure Johnson & Johnson Biosimilar Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biosimilar Sales Growth Rate (2013-2018)
Figure Novo Nordisk Biosimilar Sales Global Market Share (2013-2018
Figure Novo Nordisk Biosimilar Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biosimilar Sales Growth Rate (2013-2018)
Figure Merck Biosimilar Sales Global Market Share (2013-2018)
Figure Merck Biosimilar Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar
Figure Manufacturing Process Analysis of Biosimilar
Figure Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Major Players in 2017
Table Major Buyers of Biosimilar
Table Distributors/Traders List
Figure Global Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biosimilar Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Biosimilar Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Biosimilar Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Biosimilar Sales Volume Market Share Forecast by Regions in 2025
Table Global Biosimilar Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Biosimilar Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Biosimilar Revenue Market Share Forecast by Regions in 2025
Figure United States Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biosimilar Revenue and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Biosimilar Sales (K Units) Forecast by Type (2018-2025)
Figure Global Biosimilar Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Biosimilar Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biosimilar Revenue Market Share Forecast by Type (2018-2025)
Table Global Biosimilar Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Biosimilar Sales (K Units) Forecast by Application (2018-2025)
Figure Global Biosimilar Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources